Barclays Increases Oscar Health Price Target from $11 to $13
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 10 2025
0mins
Price Target Adjustment: Barclays analyst Andrew Mok increased Oscar Health's price target from $11 to $13 while maintaining an Underweight rating on the shares.
Rate Increase: The company is implementing a weighted-average rate increase of 28%.
Product Competitiveness: Oscar Health is introducing more competitive products in the bronze and gold tiers.
Analyst Insights: Mok shared these insights with investors in a recent research note following the company's Q3 report.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to fall
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 22.330
Low
11.00
Averages
15.75
High
25.00
Current: 22.330
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oscar Health: Potential in the Health Insurance Market
- Market Share Growth: Oscar Health's total paying members reached 3.2 million last quarter, reflecting over a 50% increase from 2 million a year ago, indicating significant market share gains in the ACA sector and positioning the company strongly in the rapidly growing health insurance market.
- Revenue Expectations Rise: Oscar Health is guiding for $19 billion in revenue at the high end for 2026, and if it can reach 10 million members, annual premiums could exceed $50 billion, presenting substantial revenue growth potential, especially amid rising healthcare costs.
- Technology-Driven Profitability: The company generated $700 million in operating income last quarter, with expectations of $250 million to $450 million in operating earnings for 2026, and as Oscar Health scales and improves technological efficiencies, its profitability is expected to significantly enhance in the coming years.
- Investor Confidence Boost: With a current market cap of $6.6 billion and a price-to-earnings ratio of 15 based on 2026 earnings guidance, Oscar Health demonstrates strong potential for profit growth over the next decade, attracting interest from long-term investors.
See More
Oscar Health's 53% Surge Still Underappreciated
- Market Share Growth: Oscar Health's paying insurance members reached 3.2 million by Q1 2026, a significant increase from just over 500,000 in Q1 2021, demonstrating strong performance in the ACA marketplace and enhancing the company's competitive edge in the health insurance sector.
- Operating Leverage Realized: In Q1 2026, Oscar Health generated $700 million in operating income, successfully increasing market share despite rising healthcare utilization, thanks to flexible pricing strategies and conservative utilization forecasts, with annual operating earnings expected to reach between $250 million and $450 million, marking a record high.
- Significant Profit Potential: With a market cap of $6.63 billion, Oscar Health remains undervalued despite a 53% stock price increase this year, especially when considering projected revenues of $19 billion and operating income of $450 million, indicating substantial long-term growth potential.
- Optimistic Industry Outlook: As the U.S. healthcare industry continues to expand, Oscar Health is poised to achieve over $30 billion in premium revenue, and with a 3% profit margin, this could translate to $900 million in annual operating income, further solidifying its market position.
See More
Oscar Health's Rapid Growth in Insurance Market
- Market Share Growth: Oscar Health has seen its membership surge to 3.2 million, a significant increase from just over 500,000 in Q1 2021, demonstrating strong performance in the ACA marketplace despite pressure from traditional competitors.
- Profitability Improvement: In Q1 2026, Oscar Health generated $700 million in operating income, marking a successful turnaround from a $400 million operating loss in 2025, showcasing the management's agile response to challenges.
- Optimistic Future Outlook: Although the company expects annual operating earnings to range between $250 million and $450 million in 2026, this would still represent a record high for the business, indicating potential for scaling and enhanced profitability.
- Attractive Valuation: With a current market cap of $6.63 billion and a 53% stock price increase this year, Oscar Health remains relatively undervalued compared to its potential future revenue of $19 billion and operating income of $450 million, reflecting its long-term growth prospects.
See More
Enrollment in ACA Plans Expected to Drop Significantly
- Enrollment Decline: KFF reports that enrollments in ACA plans could decline by up to 26% by 2026 due to the expiration of enhanced premium tax credits, significantly impacting millions of Americans relying on ACA coverage.
- Impact of Premium Hikes: With Congress failing to extend COVID-era ACA tax credits, enrollments dropped by over 1 million to 23.1 million in 2026, marking the largest single-year decline since the ACA Marketplaces' inception.
- Coverage Continuity Issues: Although about 86% of individuals enrolled in plans made their first premium payment as of January 2026, Wakely projects that effective coverage could decline by 17% to 26% on average, translating to a loss of approximately 3.8 million to 5.8 million individuals in ACA marketplaces.
- Future Loss Expectations: KFF anticipates further enrollment losses in the coming months as more individuals are expected to lose coverage due to inability to maintain increased premium payments, indicating a worsening situation for ACA health insurance coverage overall.
See More
Investment Potential of Nintendo, Oscar Health, and Adyen
- Nintendo Market Performance: Nintendo sold 20 million units of the Nintendo Switch 2 in the last fiscal year, with similar sales projected for the second year, and despite a 54% drop from its highs, long-term investors could see substantial returns.
- Oscar Health Customer Growth: Oscar Health's paying customers surged from 1 million in Q1 2022 to 3.2 million, with projected revenue of $19 billion in 2023, indicating strong expansion potential in the health insurance market.
- Adyen Payment Processing Advantage: Adyen's processed volume grew 21% year-over-year in Q1 2026, with revenue increasing by 20%, and despite a 66% decline from all-time highs, its market share in global payment processing continues to expand.
- Long-Term Investment Value: These companies demonstrate strong business durability and growth potential, particularly as they continue to increase their market shares in their respective sectors, making them suitable for long-term holding to achieve wealth accumulation.
See More
Top Stocks to Hold for the Long Term
- Nintendo's Lasting Appeal: Nintendo (NTDOY) sold 20 million units of the Switch 2 last fiscal year, with similar projections for the next year, maintaining a strong market share; despite a 54% drop from its highs, its long-term investment potential remains robust.
- Oscar Health's Market Disruption: Oscar Health (OSCR) increased its customer base from 1 million to 3.2 million over the past year, with projected revenue of $19 billion in 2023, showcasing strong expansion and improving profitability in the health insurance sector.
- Adyen's Payment Processing Edge: Adyen (ADYEY) reported a 21% year-over-year growth in processed volume and a 20% revenue increase in Q1 2026, even as its stock is down 66% from all-time highs, indicating significant growth potential in the global payments market.
- Strategic Importance of Long-Term Investment: The continuous innovation and market share growth of these companies suggest they will provide substantial returns for investors over the next 20 years, especially in the context of economic fluctuations, highlighting the enduring value of holding quality businesses.
See More
Oscar Health: Potential in the Health Insurance Market
- Market Share Growth: Oscar Health's total paying members reached 3.2 million last quarter, reflecting over a 50% increase from 2 million a year ago, indicating significant market share gains in the ACA sector and positioning the company strongly in the rapidly growing health insurance market.
- Revenue Expectations Rise: Oscar Health is guiding for $19 billion in revenue at the high end for 2026, and if it can reach 10 million members, annual premiums could exceed $50 billion, presenting substantial revenue growth potential, especially amid rising healthcare costs.
- Technology-Driven Profitability: The company generated $700 million in operating income last quarter, with expectations of $250 million to $450 million in operating earnings for 2026, and as Oscar Health scales and improves technological efficiencies, its profitability is expected to significantly enhance in the coming years.
- Investor Confidence Boost: With a current market cap of $6.6 billion and a price-to-earnings ratio of 15 based on 2026 earnings guidance, Oscar Health demonstrates strong potential for profit growth over the next decade, attracting interest from long-term investors.
See More
Oscar Health's 53% Surge Still Underappreciated
- Market Share Growth: Oscar Health's paying insurance members reached 3.2 million by Q1 2026, a significant increase from just over 500,000 in Q1 2021, demonstrating strong performance in the ACA marketplace and enhancing the company's competitive edge in the health insurance sector.
- Operating Leverage Realized: In Q1 2026, Oscar Health generated $700 million in operating income, successfully increasing market share despite rising healthcare utilization, thanks to flexible pricing strategies and conservative utilization forecasts, with annual operating earnings expected to reach between $250 million and $450 million, marking a record high.
- Significant Profit Potential: With a market cap of $6.63 billion, Oscar Health remains undervalued despite a 53% stock price increase this year, especially when considering projected revenues of $19 billion and operating income of $450 million, indicating substantial long-term growth potential.
- Optimistic Industry Outlook: As the U.S. healthcare industry continues to expand, Oscar Health is poised to achieve over $30 billion in premium revenue, and with a 3% profit margin, this could translate to $900 million in annual operating income, further solidifying its market position.
See More
Oscar Health's Rapid Growth in Insurance Market
- Market Share Growth: Oscar Health has seen its membership surge to 3.2 million, a significant increase from just over 500,000 in Q1 2021, demonstrating strong performance in the ACA marketplace despite pressure from traditional competitors.
- Profitability Improvement: In Q1 2026, Oscar Health generated $700 million in operating income, marking a successful turnaround from a $400 million operating loss in 2025, showcasing the management's agile response to challenges.
- Optimistic Future Outlook: Although the company expects annual operating earnings to range between $250 million and $450 million in 2026, this would still represent a record high for the business, indicating potential for scaling and enhanced profitability.
- Attractive Valuation: With a current market cap of $6.63 billion and a 53% stock price increase this year, Oscar Health remains relatively undervalued compared to its potential future revenue of $19 billion and operating income of $450 million, reflecting its long-term growth prospects.
See More
Enrollment in ACA Plans Expected to Drop Significantly
- Enrollment Decline: KFF reports that enrollments in ACA plans could decline by up to 26% by 2026 due to the expiration of enhanced premium tax credits, significantly impacting millions of Americans relying on ACA coverage.
- Impact of Premium Hikes: With Congress failing to extend COVID-era ACA tax credits, enrollments dropped by over 1 million to 23.1 million in 2026, marking the largest single-year decline since the ACA Marketplaces' inception.
- Coverage Continuity Issues: Although about 86% of individuals enrolled in plans made their first premium payment as of January 2026, Wakely projects that effective coverage could decline by 17% to 26% on average, translating to a loss of approximately 3.8 million to 5.8 million individuals in ACA marketplaces.
- Future Loss Expectations: KFF anticipates further enrollment losses in the coming months as more individuals are expected to lose coverage due to inability to maintain increased premium payments, indicating a worsening situation for ACA health insurance coverage overall.
See More
Investment Potential of Nintendo, Oscar Health, and Adyen
- Nintendo Market Performance: Nintendo sold 20 million units of the Nintendo Switch 2 in the last fiscal year, with similar sales projected for the second year, and despite a 54% drop from its highs, long-term investors could see substantial returns.
- Oscar Health Customer Growth: Oscar Health's paying customers surged from 1 million in Q1 2022 to 3.2 million, with projected revenue of $19 billion in 2023, indicating strong expansion potential in the health insurance market.
- Adyen Payment Processing Advantage: Adyen's processed volume grew 21% year-over-year in Q1 2026, with revenue increasing by 20%, and despite a 66% decline from all-time highs, its market share in global payment processing continues to expand.
- Long-Term Investment Value: These companies demonstrate strong business durability and growth potential, particularly as they continue to increase their market shares in their respective sectors, making them suitable for long-term holding to achieve wealth accumulation.
See More
Top Stocks to Hold for the Long Term
- Nintendo's Lasting Appeal: Nintendo (NTDOY) sold 20 million units of the Switch 2 last fiscal year, with similar projections for the next year, maintaining a strong market share; despite a 54% drop from its highs, its long-term investment potential remains robust.
- Oscar Health's Market Disruption: Oscar Health (OSCR) increased its customer base from 1 million to 3.2 million over the past year, with projected revenue of $19 billion in 2023, showcasing strong expansion and improving profitability in the health insurance sector.
- Adyen's Payment Processing Edge: Adyen (ADYEY) reported a 21% year-over-year growth in processed volume and a 20% revenue increase in Q1 2026, even as its stock is down 66% from all-time highs, indicating significant growth potential in the global payments market.
- Strategic Importance of Long-Term Investment: The continuous innovation and market share growth of these companies suggest they will provide substantial returns for investors over the next 20 years, especially in the context of economic fluctuations, highlighting the enduring value of holding quality businesses.
See More
